Page last updated: 2024-10-27

flumazenil and Severe Combined Immunodeficiency

flumazenil has been researched along with Severe Combined Immunodeficiency in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Severe Combined Immunodeficiency: Group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an X-linked or autosomal recessive defect. Mutations occurring in many different genes cause human Severe Combined Immunodeficiency (SCID).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baffelli, R1
Notarangelo, LD1
Imberti, L1
Hershfield, MS1
Serana, F1
Santisteban, I1
Bolda, F1
Porta, F1
Lanfranchi, A1

Other Studies

1 other study available for flumazenil and Severe Combined Immunodeficiency

ArticleYear
Diagnosis, Treatment and Long-Term Follow Up of Patients with ADA Deficiency: a Single-Center Experience.
    Journal of clinical immunology, 2015, Volume: 35, Issue:7

    Topics: Adenosine Deaminase; Agammaglobulinemia; Child, Preschool; Consanguinity; DNA Mutational Analysis; E

2015